Cargando...

A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer

To explore the parmacokinetics, safety and tolerability of paclitaxel after oral administration of SMEOF#3, a novel Self-Microemulsifying Oily Formulation, in combination with cyclosporin A (CsA) in patients with advanced cancer. Seven patients were enrolled and randomly assigned to receive oral pac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Veltkamp, S A, Thijssen, B, Garrigue, J S, Lambert, G, Lallemand, F, Binlich, F, Huitema, A D R, Nuijen, B, Nol, A, Beijnen, J H, Schellens, J H M
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2006
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360510/
https://ncbi.nlm.nih.gov/pubmed/16926835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603312
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!